Cite
HARVARD Citation
Desmedt, C. et al. (2018). Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index. Journal of the National Cancer Institute. pp. 1115-1122. [Online].